Effects of Plasmodium falciparum-infected erythrocytes on matrix metalloproteinase-9 regulation in human microvascular endothelial cells

Asian Pacific Journal of Tropical Medicine

Volumn 6, Issue 3, 2013, Pages 195-199

  D'Alessandro, Sarah ^a   Basilico, Nicoletta ^a   Prato, Mauro ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Endothelial cells; Gelatinases; Malaria; Matrix metalloproteinases; Plasmodium falciparum; Tissue inhibitors of metalloproteinases

Indexed keywords

CHLOROQUINE; ENZYME ACTIVATOR; ENZYME INHIBITOR; ENZYME PRECURSOR; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; DENSITOMETRY; DRUG EFFECT; DRUG TARGETING; ENZYME REGULATION; ENZYME RELEASE; ERYTHROCYTE; GENETIC STRAIN; HUMAN; HUMAN CELL; INCUBATION TIME; MALARIA FALCIPARUM; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN SECRETION; SUPERNATANT; TROPHOZOITE; WESTERN BLOTTING; ZYMOGRAPHY;

BLOTTING, WESTERN; DENSITOMETRY; ENDOTHELIAL CELLS; ERYTHROCYTES; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; PLASMODIUM FALCIPARUM; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84873163630     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(13)60022-X     Document Type: Article

References (36)

1. Malaria overview. [Online] [Accessed on 2010]. http://www.gatesfoundation.org/topics/Pages/malaria.aspx.
2. John CC, Kutamba E, Mugarura K, Opoka RO Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria. Expert Rev Anti Infect Ther 2010, 8:997-1008.
3. Prato M, Giribaldi G Matrix metalloproteinase-9 and haemozoin: Wedding rings for human Host and Plasmodium falciparum parasite in complicated malaria. J Trop Med 2011, 2011:ID628435.
4. Geurts N, Opdenakker G, Van den Steen PE Matrix metalloproteinases as therapeutic targets in protozoan parasitic infections. Pharmacol Ther 2012, in press.
5. Prato M Role of human matrix metalloproteinases in malaria pathogenesis. Malaria: Etiology, pathogenesis and treatments 2012, Nova Science Publishers, Hauppage, NY, (in press). 1st Ed.
6. Prato M Role of blood-brain barrier in cerebral malaria. The blood-brain barrier: New research 2012, Nova Science Publishers, Hauppage, NY, (in press). 1st Ed.
7. Cauwe B, Van den Steen PE, Opdenakker G The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 2007, 42:113-185.
8. Deininger MH, Winkler S, Kremsner PG, Meyermann R, Schluesener HJ Angiogenic proteins in brains of patients who died with cerebral malaria. J Neuroimmunol 2003, 142:101-111.
9. Griffiths MJ, Shafi MJ, Popper SJ, Hemingway CA, Kortok MM, Wathen A, et al. Genomewide analysis of the host response to malaria in Kenyan children. J Infect Dis 2005, 191:1599-1611.
10. Dietmann A, Helbok R, Lackner P, Issifou S, Lell B, Matsiegui PB, et al. Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity. J Infect Dis 2008, 197:1614-1620.
11. Van den Steen PE, Van Aelst I, Starckx S, Maskos K, Opdenakker G, Pagenstecher A Matrix metalloproteinases, tissue inhibitors of MMPs and TACE in experimental cerebral malaria. Lab Invest 2006, 86:873-888.
12. Szklarczyk A, Stins M, Milward EA, Ryu H, Fitzsimmons C, Sullivan D, et al. Glial activation and matrix metalloproteinase release in cerebral malaria. J Neurovirol 2007, 13:2-10.
13. Prato M, Giribaldi G, Polimeni M, Gallo V, Arese P Phagocytosis of hemozoin enhances matrix metalloproteinase-9 activity and TNF-alpha production in human monocytes: role of matrix metalloproteinases in the pathogenesis of falciparum malaria. J Immunol 2005, 175:6436-6442.
14. Prato M, Gallo V, Giribaldi G, Arese P Phagocytosis of haemozoin (malarial pigment) enhances metalloproteinase-9 activity in human adherent monocytes: role of IL-1beta and 15-HETE. Malar J 2008, 7:157.
15. Giribaldi G, Prato M, Ulliers D, Gallo V, Schwarzer E, Akide-Ndunge OB, et al. Involvement of inflammatory chemokines in survival of human monocytes fed with malarial pigment. Infect Immun 2010, 78:4912-4921.
16. Prato M, Gallo V, Giribaldi G, Aldieri E, Arese P Role of the NF-B transcription pathway in the hemozoin- and 15-HETE-mediated activation of matrix metalloproteinase-9 in human adherent monocytes. Cell Microbiol 2010, 12:1780-1791.
17. Dell'agli M, Galli GV, Bulgari M, Basilico N, Romeo S, Bhattacharya D, et al. Ellagitannins of the fruit rind of pomegranate (Punica granatum) antagonize in vitro the host inflammatory response mechanisms involved in the onset of malaria. Malar J 2010, 9:208.
18. Schrimpe AC, Wright DW Comparative analysis of gene expression changes mediated by individual constituents of hemozoin. Chem Res Toxicol 2009, 22:433-445.
19. Hanemaaijer R, Koolwijk P, le Clercq L, de Vree WJ, van Hinsbergh VW Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem J 1993, 296:803-809.
20. Mauro A, Buscemi M, Gerbino A Immunohistochemical and transcriptional expression of matrix metalloproteinases in full-term human umbilical cord and human umbilical vein endothelial cells. J Mol Histol 2010, 41:367-377.
21. Prato M, D'Alessandro S, Van den Steen PE, Opdenakker G, Arese P, Taramelli D, et al. Natural haemozoin modulates matrix metalloproteinases and induces morphological changes in human microvascular endothelium. Cell Microbiol 2011, 13:1275-1285.
22. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992, 99:683-690.
23. Omodeo-Salè F, Motti A, Basilico N, Parapini S, Olliaro P, Taramelli D Accelerated senescence of human erythrocytes cultured with Plasmodium falciparum. Blood 2003, 102:705-711.
24. Ochola LB, Siddondo BR, Ocholla H, Nkya S, Kimani EN, Williams TN, et al. Specific receptor usage in Plasmodium falciparum cytoadherence is associated with disease outcome. PLoS One 2011, 6:e14741.
25. Pongponratn E, Turner GD, Day NP, Phu NH, Simpson JA, Stepniewska K, et al. An ultrastructural study of the brain in fatal Plasmodium falciparum malaria. Am J Trop Med Hyg 2003, 69:345-359.
26. Tripathi AK, Sha W, Shulaev V, Stins MF, Sullivan DJ Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium. Blood 2009, 114:4243-4252.
27. Basilico N, Speciale L, Parapini S, Ferrante P, Taramelli D Endothelin-1 production by a microvascular endothelial cell line treated with Plasmodium falciparum parasitized red blood cells. Clin Sci (Lond) 2002, 103:464S-466S.
28. Basilico N, Mondani M, Parapini S, Speciale L, Ferrante P, Taramelli D Plasmodium falciparum parasitized red blood cells modulate the production of endothelin-1 by human endothelial cells. Minerva Med 2004, 95:153-158.
29. Tripathi AK, Sullivan DJ, Stins MF Plasmodium falciparum-infected erythrocytes decrease the integrity of human blood-brain barrier endothelial cell monolayers. J Infect Dis 2007, 195:942-950.
30. World Health Organisation Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000, 94(Suppl 1):1-90.
31. Geurts N, Martens E, Van Aelst I, Proost P, Opdenakker G, Van den Steen PE Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3. Biochemistry 2008, 47:2689-2699.
32. Brew K, Dinakarpandian D, Nagase H Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000, 1477:267-283.
33. Lijnen HR Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 2001, 86:324-333.
34. Fauser S, Deininger MH, Kremsner PG, Magdolen V, Luther T, Meyermann R, et al. Lesion associated expression of urokinase-type plasminogen activator receptor (uPAR, CD87) in human cerebral malaria. J Neuroimmunol 2000, 111:234-240.
35. Chen F, Ohashi N, Li W, Eckman C, Nguyen JH Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure. Hepatology 2009, 50:1914-1923.
36. Agrawal S, Anderson P, Durbeej M, van Rooijen N, Ivars F, Opdenakker G, et al. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J Exp Med 2006, 203:1007-1019.